Dapagliflozin
| CAS No. | 461432-26-8 |
|---|---|
| MDL No. | MFCD13182359 |
| MF | C21H25ClO6 |
| MW | 408.90 |
| InChI Key | JVHXJTBJCFBINQ-ADAARDCZSA-N |
| CAS No. | 461432-26-8 |
|---|---|
| MDL No. | MFCD13182359 |
| MF | C21H25ClO6 |
| MW | 408.90 |
| InChI Key | JVHXJTBJCFBINQ-ADAARDCZSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Dapagliflozin is a C-glycosyl compound containing beta-D-glucose, where the anomeric hydroxy group is substituted with a 4-chloro-3-(4-ethoxybenzyl)phenyl group. It is used as its propanediol monohydrate form to improve glycemic control in adults with type 2 diabetes, alongside diet and exercise. Dapagliflozin functions as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor. It is also classified as an aromatic ether and a member of the monochlorobenzenes.
| CAS No. | 461432-26-8 |
|---|---|
| Product Name | Dapagliflozin |